IDX375

IDX375 is a novel non-nucleoside inhibitor with selective inhibitory activity against HCV NS5B. IDX375 has good selectivity for genotypes 1a and 1b. The structure and binding site of IDX375 were confirmed by X-ray cocrystal studies[1].

Product Specifications

CAS Number

[1162665-52-2]

UNSPSC

12352005

Target

Endogenous Metabolite

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/idx375.html

Smiles

CS(=O)(NC1=CC=C(C2=C1)NC(C3=C(O)[C@H](C(C)(C)C)N(CCC(C)(C)C)C3=O)=N[P@]2(OCC)=O)=O

Molecular Formula

C24H37N4O6PS

Molecular Weight

540.61

References & Citations

[1]Discovery of benzophosphadiazine drug candidate IDX375: A novel hepatitis C allosteric NS5B RdRp inhibitor

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

125043-FITC 100 µL

CLDN15 (Claudin-15, Claudin 15, FLJ42715, MGC19536) (FITC)

Ask

View Details

VAnt-Wyb508 Each

Staphylococcus aureus Monoclonal Antibody

Ask

View Details

49405036 100 µg

UXS1 Protein Lysate (Rat) with C-HA Tag

Ask

View Details

RG-1213 5x 10^6

K562-BCMA Overexpressing Cell Line

Ask

View Details

NBP2-97125JF549 0.1 mL

Rabbit Polyclonal Collagen VI alpha 3 Antibody [Janelia Fluor 549]

Ask

View Details